Advanced search
Publication Cover
OncoImmunology Volume 7, 2018 - Issue 2
Submit an article Journal homepage
1,957
Views
27
CrossRef citations to date
0
Altmetric
Original Research

Citrullinated α-enolase is an effective target for anti-cancer immunity

Katherine CookScancell Limited, Academic Department of Clinical Oncology, University of Nottingham, City Hospital Campus, Nottinghamshire, UK
,
Ian DanielsScancell Limited, Academic Department of Clinical Oncology, University of Nottingham, City Hospital Campus, Nottinghamshire, UK
,
Peter SymondsScancell Limited, Academic Department of Clinical Oncology, University of Nottingham, City Hospital Campus, Nottinghamshire, UK
,
Tracy PittScancell Limited, Academic Department of Clinical Oncology, University of Nottingham, City Hospital Campus, Nottinghamshire, UK
,
Mohamed GijonScancell Limited, Academic Department of Clinical Oncology, University of Nottingham, City Hospital Campus, Nottinghamshire, UKORCID Iconhttps://orcid.org/0000-0002-2444-0727
ORCID Icon,
Wei XueScancell Limited, Academic Department of Clinical Oncology, University of Nottingham, City Hospital Campus, Nottinghamshire, UK
,
Rachael MetheringhamScancell Limited, Academic Department of Clinical Oncology, University of Nottingham, City Hospital Campus, Nottinghamshire, UK
,
Lindy DurrantScancell Limited, Academic Department of Clinical Oncology, University of Nottingham, City Hospital Campus, Nottinghamshire, UK;Academic Department of Clinical Oncology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, City Hospital Campus, Nottinghamshire, UKCorrespondence[email protected]
&
Victoria BrentvilleScancell Limited, Academic Department of Clinical Oncology, University of Nottingham, City Hospital Campus, Nottinghamshire, UK
 show all
Article: e1390642 | Received 06 Sep 2017, Accepted 05 Oct 2017, Published online: 06 Nov 2017

Citations (27)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Yue-Yu Shi, Xing-Lei Chen, Qian-Xin Chen, Yuan-Zhong Yang, Meng Zhou, Yue-Xiang Ren, Lu-Ying Tang & Ze-Fang Ren. (2023) Association of Enolase-1 with Prognosis and Immune Infiltration in Breast Cancer by Clinical Stage. Journal of Inflammation Research 16, pages 493-503.
Read now

Articles from other publishers (26)

Sabaria Shah, Katherine W Cook, Peter Symonds, Juliane Weißer, Anne Skinner, Abdullah Al Omari, Samantha J Paston, Ian Pike, Lindy G Durrant & Victoria A Brentville. (2023) Vaccination with post-translational modified, homocitrullinated peptides induces CD8 T-cell responses that mediate antitumor immunity. Journal for ImmunoTherapy of Cancer 11:10, pages e006966.
Crossref
Xiangmei Wu, Yuji Wang & Wenjing Wang. (2023) The Role of Peptidyl Arginine Deiminase IV(PADI4) in Cancers. Anti-Cancer Agents in Medicinal Chemistry 23:3, pages 256-265.
Crossref
Kristin J. Lastwika, Andrew Kunihiro, Joell L. Solan, Yuzheng ZhangLydia R. Taverne, David ShelleyJung-Hyun Rho, Timothy W. Randolph, Christopher I. Li, Eric L. Grogan, Pierre P. MassionAnnette L. FitzpatrickDavid MacPhersonA. McGarry Houghton & Paul D. Lampe. (2023) Posttranslational modifications induce autoantibodies with risk prediction capability in patients with small cell lung cancer. Science Translational Medicine 15:678.
Crossref
Sabaria Shah, Abdullah Al-Omari, Katherine W Cook, Samantha J Paston, Lindy G Durrant & Victoria A Brentville. (2023) What do cancer-specific T cells ‘see’?. Discovery Immunology 2:1.
Crossref
Anurag Kumar Srivastava, Giorgia Guadagnin, Paola Cappello & Francesco Novelli. (2022) Post-Translational Modifications in Tumor-Associated Antigens as a Platform for Novel Immuno-Oncology Therapies. Cancers 15:1, pages 138.
Crossref
Victoria Anne Brentville, Peter Symonds, JiaXin Chua, Anne Skinner, Ian Daniels, Katherine Wendy Cook, Sasa Koncarevic, Roxana Martinez-Pinna, Sabaria Shah, Ruhul Hasan Choudhury, Poonam Vaghela, Daisy Weston, Abdullah Al-Omari, James Davis & Lindy G. Durrant. (2022) Citrullinated glucose-regulated protein 78 is a candidate target for melanoma immunotherapy. Frontiers in Immunology 13.
Crossref
Pekka Rappu, Ujjwal Suwal, Elina Siljamäki & Jyrki Heino. (2022) Inflammation-related citrullination of matrisome proteins in human cancer. Frontiers in Oncology 12.
Crossref
Angelika Hermawan, Fedric Intan Damai, Leon Martin, Matthew Chrisdianto, Nadya Marcelina Julianto, Ihsan Tria Pramanda & Marsia Gustiananda. (2022) Immunoinformatics Analysis of Citrullinated Antigen as Potential Multi-peptide Lung Cancer Vaccine Candidates for Indonesian Population. International Journal of Peptide Research and Therapeutics 28:6.
Crossref
Ricardo A. León-Letelier, Hiroyuki Katayama & Sam Hanash. (2022) Mining the Immunopeptidome for Antigenic Peptides in Cancer. Cancers 14:20, pages 4968.
Crossref
Tatyana Sandalova, Benedetta Maria Sala & Adnane Achour. (2022) Structural aspects of chemical modifications in the MHC-restricted immunopeptidome; Implications for immune recognition. Frontiers in Chemistry 10.
Crossref
Joanna Sarnik & Joanna Samanta Makowska. (2022) Highlighting the versatility of the citrullination process. Immunobiology 227:4, pages 152233.
Crossref
Katherine Cook, Wei Xue, Suha Atabani, Peter Symonds, Abdullah Al Omari, Ian Daniels, Sabaria Shah, Ruhul Hasan Choudhury, Daisy Weston, Rachael Metheringham, Victoria Brentville & Lindy Durrant. (2022) Vaccine Can Induce CD4-Mediated Responses to Homocitrullinated Peptides via Multiple HLA-Types and Confer Anti-Tumor Immunity. Frontiers in Immunology 13.
Crossref
Ruhul H Choudhury, Peter Symonds, Samantha J Paston, Ian Daniels, Katherine W Cook, Mohamed Gijon, Rachael L Metheringham, Victoria A Brentville & Lindy G Durrant. (2022) PAD-2-mediated citrullination of nucleophosmin provides an effective target for tumor immunotherapy. Journal for ImmunoTherapy of Cancer 10:2, pages e003526.
Crossref
Katherine W Cook, Wei Xue, Peter Symonds, Ian Daniels, Mohamed Gijon, David Boocock, Clare Coveney, Amanda K Miles, Sabaria Shah, Suha Atabani, Ruhul H Choudhury, Poonam Vaghela, Daisy Weston, Rachael L Metheringham, Victoria A Brentville & Lindy G Durrant. (2021) Homocitrullination of lysine residues mediated by myeloid-derived suppressor cells in the tumor environment is a target for cancer immunotherapy. Journal for ImmunoTherapy of Cancer 9:7, pages e001910.
Crossref
Hiroyuki Katayama, Makoto Kobayashi, Ehsan Irajizad, Alejandro M Sevillano, Nikul Patel, Xiangying Mao, Leona Rusling, Jody Vykoukal, Yining Cai, Fuchung Hsiao, Chuan-Yih Yu, James Long, Jinsong Liu, Franscisco Esteva, Johannes Fahrmann & Sam Hanash. (2021) Protein citrullination as a source of cancer neoantigens. Journal for ImmunoTherapy of Cancer 9:6, pages e002549.
Crossref
Samantha J. Paston, Victoria A. Brentville, Peter Symonds & Lindy G. Durrant. (2021) Cancer Vaccines, Adjuvants, and Delivery Systems. Frontiers in Immunology 12.
Crossref
Claudia Curcio, Silvia Brugiapaglia, Sara Bulfamante, Laura Follia, Paola Cappello & Francesco Novelli. (2021) The Glycolytic Pathway as a Target for Novel Onco-Immunology Therapies in Pancreatic Cancer. Molecules 26:6, pages 1642.
Crossref
Pinar Uysal-Onganer, Stefania D’Alessio, Maria Mortoglou, Igor Kraev & Sigrun Lange. (2021) Peptidylarginine Deiminase Inhibitor Application, Using Cl-Amidine, PAD2, PAD3 and PAD4 Isozyme-Specific Inhibitors in Pancreatic Cancer Cells, Reveals Roles for PAD2 and PAD3 in Cancer Invasion and Modulation of Extracellular Vesicle Signatures. International Journal of Molecular Sciences 22:3, pages 1396.
Crossref
Frankis A. Almaguel, Tino W. Sanchez, Greisha L. Ortiz-Hernandez & Carlos A. Casiano. (2021) Alpha-Enolase: Emerging Tumor-Associated Antigen, Cancer Biomarker, and Oncotherapeutic Target. Frontiers in Genetics 11.
Crossref
Yu Zhang, Yiqiong Yang, Xiuxiu Hu, Zhi Wang, Li Li & Pingsheng Chen. (2021) PADs in cancer: Current and future. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1875:1, pages 188492.
Crossref
Victoria A Brentville, Rachael L Metheringham, Ian Daniels, Suha Atabani, Peter Symonds, Katherine W Cook, Mireille Vankemmelbeke, Ruhul Choudhury, Poonam Vaghela, Mohamed Gijon, Ghislaine Meiners, Willem-Jan Krebber, Cornelis J M Melief & Lindy G Durrant. (2020) Combination vaccine based on citrullinated vimentin and enolase peptides induces potent CD4-mediated anti-tumor responses. Journal for ImmunoTherapy of Cancer 8:1, pages e000560.
Crossref
V.A. Brentville, M. Vankemmelbeke, R.L. Metheringham & L.G. Durrant. (2020) Post-translational modifications such as citrullination are excellent targets for cancer therapy. Seminars in Immunology 47, pages 101393.
Crossref
Jacob S. Bowers, Stefanie R. Bailey, Mark P. Rubinstein, Chrystal M. Paulos & E. Ramsay Camp. (2019) Genomics meets immunity in pancreatic cancer: Current research and future directions for pancreatic adenocarcinoma immunotherapy. Oncology Reviews 13:2.
Crossref
Arseniy E. Yuzhalin. (2019) Citrullination in Cancer. Cancer Research 79:7, pages 1274-1284.
Crossref
Shuzheng Song & Yingyan Yu. (2019) Progression on Citrullination of Proteins in Gastrointestinal Cancers. Frontiers in Oncology 9.
Crossref
Katherine Cook, Lindy Durrant & Victoria Brentville. (2018) Current Strategies to Enhance Anti-Tumour Immunity. Biomedicines 6:2, pages 37.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.